| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.006 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.009 |